SIRT1 activators (Asahi Kasei Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSIRT1 activators (Asahi Kasei Pharma)
Drug Alias Nameindazole derivatives (Asahi Kasei Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Pharma Corp
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A